However, different from the results found in breast cancer that TRIM62 acted as a master regulator on EMT by blocking TGF-β signaling [21], the results of Multi-pathway reporter array showed that in CC TGF-β signaling was not significantly affected by TRIM62. The gene discussed is TRIM62; the disease is breast cancer.